Publications, Pharmaceutical

Microbial integrity testing for preservative-free drug formulations

Preservative-free formulation can protect patients from the adverse effects of additives and is a growing trend in eye care and nasal drug products.

This paper presents a new tip seal integrity test – TSIT 2.0 – that provides a reasonable and representative challenge for preservative-free solutions with respect to their ability to safeguard microbial integrity. The test uses three germs rather than pseudomonas aeruginosa alone and involves repeated submersion of the discharge orifice during actuation. It is simple, and test duration is relatively short with results generated over a 10-day period. Experimental data are presented to illustrate the application of the new TSIT 2.0 test to an eyedropper. The test is the culmination of a long series of experiments and the results confirm its efficacy for testing the ability of antimicrobial measures to preserve microbial integrity.

Download Publication
3 Jun 2019

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More

This Might Also Be of Interest

15 Mar 2022

An Eye on the Future of Preservative-Free Drops

Publications, Pharmaceutical, Product Solutions, Device Innovations, Brand Differentiation, Market Insights

Read More
25 Feb 2022

Aptar Pharma discusses intranasal administration for CNS therapeutics

Webinars, Pharmaceutical, Product Solutions, Device Innovations, Brand Differentiation, Market Insights

Read More
15 Feb 2022

New solutions for pre-clinical discovery in respiratory healthcare

Webinars, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
28 Jan 2022

Improving Intranasal Sprays for Respiratory Viral Infections

Publications, Pharmaceutical, Product Solutions, Device Innovations, Brand Differentiation

Read More
1 14 15 16 17 18 29
Back To Top